BioMaxima S.A. (WSE:BMX)
Poland flag Poland · Delayed Price · Currency is PLN
12.85
+0.05 (0.39%)
At close: Feb 5, 2026

BioMaxima Company Description

BioMaxima S.A. produces and distributes microbiological media, reagents, and in vitro diagnostic equipment in Poland.

It offers microbiology products, including ready to use media, such as plates, bottles, bags, and media in tubes; dehydrated media; agars and peptones; and supplements.

The company also provides molecular biology and cell culture products which includes real time PCR, nucleic acid isolation, NA and PCR electrophoresis, protein electrophoresis, enzymes, antibiotics, agaroses and molecular biology media, media and buffers for in vitro cultures, phenotypic micromatrices, plastics and small equipment, basic substrate components, and form.

In addition, it offers laboratory diagnostics solutions for various areas of clinical chemistry, haematology, coagulology, immunochemistry, POCT, rapid tests, and blood collection systems; and disposable materials comprising microbiology, dispensing equipment, tubes, plugs, tripods, capillaries, equipment, aspiration-vacuum system, containers, tank for analysers, urine analysis, microscope slides, reagent tubes, autoclave equipment, and pliers and scissors.

BioMaxima S.A. was founded in 1997 and is headquartered in Lublin, Poland.

BioMaxima S.A.
CountryPoland
Founded1997
IndustryDiagnostics & Research
SectorHealthcare
Employees135
CEOLukasz Urban

Contact Details

Address:
ul. Vetterów 5
Lublin, 20-277
Poland
Phone48 81 440 83 71
Websitebiomaxima.com

Stock Details

Ticker SymbolBMX
ExchangeWarsaw Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyPLN
ISIN NumberPLBIOMX00015
SIC Code3845

Key Executives

NamePosition
Lukasz UrbanPresident of the Management Board
Henryk LewczukChief Financial Officer and Member of the Management Board
Piotr JanowskiChief Operating Officer and Member of the Management Board
Zaneta HomendaChief Accounting Officer